{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:04:14Z","timestamp":1788447854833,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA032444 and DA015014"],"award-info":[{"award-number":["DA032444 and DA015014"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA032444 and DA015014"],"award-info":[{"award-number":["DA032444 and DA015014"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA032444 and DA015014"],"award-info":[{"award-number":["DA032444 and DA015014"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA032444 and DA015014"],"award-info":[{"award-number":["DA032444 and DA015014"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA032444 and DA015014"],"award-info":[{"award-number":["DA032444 and DA015014"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>NeuroHIV and other neurologic disorders present with altered iron metabolism in central nervous system neurons. Many people with HIV also use opioids, which can worsen neuroHIV symptoms by further dysregulating neuronal iron metabolism. Our previous work demonstrated that the \u03bc-opioid agonist morphine causes neuronal endolysosomes to release their iron stores, and neurons respond by upregulating ferritin heavy chain (FHC), an iron storage protein associated with cognitive impairment in neuroHIV. Here, we investigated if this process required divalent metal transporter 1 (DMT1), a well-known iron transporter expressed on endolysosomes. We first optimized conditions to detect DMT1 isoforms (DMT1 1B\u2009\u00b1\u2009iron responsive element) using fluorescently labeled rat DMT1 constructs expressed in HEK-293 cells. We also expressed these constructs in primary rat cortical neurons to compare their expression and subcellular distribution with endogenous DMT1 isoforms. We found endogenous DMT1 isoforms in the cytoplasm that colocalized with lysosomal-associated protein 1 (LAMP1), a marker of endolysosomes. Next, we blocked endogenous DMT1 isoforms using ebselen, a potent pharmacological inhibitor of DMT1 iron transport. Ebselen pre-treatment blocked morphine\u2019s ability to upregulate FHC protein, suggesting this pathway requires DMT1 iron transport from endolysosomes. This was further validated using viral-mediated genetic silencing of DMT1\u00b1IRE in cortical neurons, which also blocked FHC upregulation in the presence of morphine. Overall, our work demonstrates that the \u03bc-opioid agonist morphine utilizes the endolysosomal iron transporter DMT1 to modulate neuronal cellular iron metabolism, upregulate FHC protein, and contribute to cognitive decline in neuroHIV.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>\n                \n                <jats:p>Morphine requires DMT1 to upregulate neuronal FHC. Cortical neurons treated with morphine release their endolysosomal iron stores to the cytoplasm and upregulate FHC, an iron storage protein associated with dendritic spine deficits and cognitive impairment in neuroHIV. This pathway requires the endolysosomal iron transporter DMT1, as pharmacological and genetic inhibitors of the transporter completely block morphine\u2019s ability to upregulate FHC. Created with <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.biorender.com\/\">BioRender.com<\/jats:ext-link>.<\/jats:p>","DOI":"10.1007\/s11481-023-10082-x","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:02:20Z","timestamp":1693785740000},"page":"495-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Endolysosomal Transporter DMT1 is Required for Morphine Regulation of Neuronal Ferritin Heavy Chain"],"prefix":"10.1007","volume":"18","author":[{"given":"Elena","family":"Irollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Luchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Brandimarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Meucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"10082_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104670","volume":"134","author":"Z Afghah","year":"2020","unstructured":"Afghah Z, Chen X, Geiger JD (2020) Role of endolysosomes and inter-organellar signaling in brain disease. Neurobiol Dis 134:104670","journal-title":"Neurobiol Dis"},{"key":"10082_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41580-019-0185-4","volume":"21","author":"A Ballabio","year":"2020","unstructured":"Ballabio A, Bonifacino JS (2020) Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol 21:101\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10082_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jnr.490350513","volume":"35","author":"GJ Brewer","year":"1993","unstructured":"Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35:567\u2013576","journal-title":"J Neurosci Res"},{"key":"10082_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/aid.2014.0169","volume":"31","author":"HC Chang","year":"2015","unstructured":"Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H (2015) Short communication: high cellular iron levels are associated with increased HIV infection and replication. AIDS Res Hum Retroviruses 31:305\u2013312","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10082_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuron.2006.07.011","volume":"51","author":"JH Cheah","year":"2006","unstructured":"Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE 3rd, Papadopoulos V, Snyder SH (2006) NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51:431\u2013440","journal-title":"Neuron"},{"key":"10082_CR6","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11682-019-00153-0","volume":"14","author":"Fennema-Notestine C, Thornton-Wells TA, Hulgan T, Letendre S, Ellis RJ, Franklin DR Jr, Anderson AM, Heaton RK, Bloss CS, Grant I, Kallianpur AR, Group CS","year":"2020","unstructured":"Fennema-Notestine C, Thornton-Wells TA, Hulgan T, Letendre S, Ellis RJ, Franklin DR Jr, Anderson AM, Heaton RK, Bloss CS, Grant I, Kallianpur AR, Group CS (2020) Iron-regulatory genes are associated with Neuroimaging measures in HIV infection. Brain Imaging Behav 14:2037\u20132049","journal-title":"Brain Imaging Behav"},{"key":"10082_CR7","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/cercor\/bhl104","volume":"17","author":"I Ferezou","year":"2007","unstructured":"Ferezou I, Hill EL, Cauli B, Gibelin N, Kaneko T, Rossier J, Lambolez B (2007) Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons. Cereb Cortex 17:1948\u20131957","journal-title":"Cereb Cortex"},{"key":"10082_CR8","doi-asserted-by":"crossref","unstructured":"Festa LK, Irollo E, Platt BJ, Tian Y, Floresco S, Meucci O (2020) CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility. Elife 9","DOI":"10.7554\/eLife.49717"},{"key":"10082_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1039\/C7MT00143F","volume":"9","author":"E Gammella","year":"2017","unstructured":"Gammella E, Buratti P, Cairo G, Recalcati S (2017) The transferrin receptor: the cellular iron gate. Metallomics 9:1367\u20131375","journal-title":"Metallomics"},{"key":"10082_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","volume":"1173","author":"G Gao","year":"2019","unstructured":"Gao G, Li J, Zhang Y, Chang YZ (2019) Cellular Iron Metabolism and Regulation. Adv Exp Med Biol 1173:21\u201332","journal-title":"Adv Exp Med Biol"},{"key":"10082_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.112.192880","volume":"342","author":"C Grimm","year":"2012","unstructured":"Grimm C, Hassan S, Wahl-Schott C, Biel M (2012) Role of TRPML and two-pore channels in endolysosomal cation homeostasis. J Pharmacol Exp Ther 342:236\u2013244","journal-title":"J Pharmacol Exp Ther"},{"key":"10082_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1084\/jem.189.5.831","volume":"189","author":"S Gruenheid","year":"1999","unstructured":"Gruenheid S, Canonne-Hergaux F, Gauthier S, Hackam DJ, Grinstein S, Gros P (1999) The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med 189:831\u2013841","journal-title":"J Exp Med"},{"key":"10082_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/41343","volume":"388","author":"H Gunshin","year":"1997","unstructured":"Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482\u2013488","journal-title":"Nature"},{"key":"10082_CR14","doi-asserted-by":"crossref","unstructured":"Halcrow PW, Kumar N, Hao E, Khan N, Meucci O, Geiger JD (2022a) Mu opioid receptor-mediated release of endolysosome iron increases levels of mitochondrial iron, reactive oxygen species, and cell death. Neuroimmune Pharmacol Ther 2(1):19\u201335","DOI":"10.1515\/nipt-2022-0013"},{"key":"10082_CR15","doi-asserted-by":"crossref","unstructured":"Halcrow PW, Kumar N, Quansah DNK, Baral A, Liang B, Geiger JD (2022b) Endolysosome Iron Chelation Inhibits HIV-1 Protein-Induced Endolysosome De-Acidification-Induced Increases in Mitochondrial Fragmentation, Mitophagy, and Cell Death. Cells 11","DOI":"10.3390\/cells11111811"},{"key":"10082_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11481-021-09995-2","volume":"17","author":"PW Halcrow","year":"2022","unstructured":"Halcrow PW, Lakpa KL, Khan N, Afghah Z, Miller N, Datta G, Chen X, Geiger JD (2022c) HIV-1 gp120-Induced Endolysosome de-Acidification Leads to Efflux of Endolysosome Iron, and Increases in Mitochondrial Iron and Reactive Oxygen Species. J Neuroimmune Pharmacol 17:181\u2013194","journal-title":"J Neuroimmune Pharmacol"},{"key":"10082_CR17","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.1073\/pnas.0904880106","volume":"106","author":"J Howitt","year":"2009","unstructured":"Howitt J, Putz U, Lackovic J, Doan A, Dorstyn L, Cheng H, Yang B, Chan-Ling T, Silke J, Kumar S, Tan SS (2009) Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. Proc Natl Acad Sci USA 106:15489\u201315494","journal-title":"Proc Natl Acad Sci USA"},{"key":"10082_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41380-019-0480-7","volume":"26","author":"C Jiang","year":"2021","unstructured":"Jiang C, Wang X, Le Q, Liu P, Liu C, Wang Z, He G, Zheng P, Wang F, Ma L (2021) Morphine coordinates SST and PV interneurons in the prelimbic cortex to disinhibit pyramidal neurons and enhance reward. Mol Psychiatry 26:1178\u20131193","journal-title":"Mol Psychiatry"},{"key":"10082_CR19","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1021\/bi052307m","volume":"45","author":"S Lam-Yuk-Tseung","year":"2006","unstructured":"Lam-Yuk-Tseung S, Gros P (2006) Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2). Biochemistry 45:2294\u20132301","journal-title":"Biochemistry"},{"key":"10082_CR20","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.3233\/JAD-179944","volume":"64","author":"DJR Lane","year":"2018","unstructured":"Lane DJR, Ayton S, Bush AI (2018) Iron and Alzheimer\u2019s Disease: An Update on Emerging Mechanisms. J Alzheimers Dis 64:S379\u2013S395","journal-title":"J Alzheimers Dis"},{"key":"10082_CR21","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1073\/pnas.0406797102","volume":"102","author":"D Liao","year":"2005","unstructured":"Liao D, Lin H, Law PY, Loh HH (2005) Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci USA 102:1725\u20131730","journal-title":"Proc Natl Acad Sci USA"},{"key":"10082_CR22","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.1523\/JNEUROSCI.3262-17.2018","volume":"38","author":"C Liu","year":"2018","unstructured":"Liu C, Zhang CW, Lo SQ, Ang ST, Chew KCM, Yu D, Chai BH, Tan B, Tsang F, Tai YK, Tan BWQ, Liang MC, Tan HT, Tang JY, Lai MKP, Chua JJE, Chung MCM, Khanna S, Lim KL, Soong TW (2018) S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit. J Neurosci 38:8364\u20138377","journal-title":"J Neurosci"},{"key":"10082_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/BJ20061290","volume":"403","author":"B Mackenzie","year":"2007","unstructured":"Mackenzie B, Takanaga H, Hubert N, Rolfs A, Hediger MA (2007) Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem J 403:59\u201369","journal-title":"Biochem J"},{"key":"10082_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00702-020-02149-3","volume":"127","author":"H Mochizuki","year":"2020","unstructured":"Mochizuki H, Choong CJ, Baba K (2020) Parkinson\u2019s disease and iron. J Neural Transm (vienna) 127:181\u2013187","journal-title":"J Neural Transm (vienna)"},{"key":"10082_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00018-020-03595-8","volume":"78","author":"MH Nam","year":"2021","unstructured":"Nam MH, Won W, Han KS, Lee CJ (2021) Signaling mechanisms of mu-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation. Cell Mol Life Sci 78:415\u2013426","journal-title":"Cell Mol Life Sci"},{"key":"10082_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-0716-0884-5_13","volume":"2201","author":"B Nash","year":"2021","unstructured":"Nash B, Irollo E, Brandimarti R, Meucci O (2021) Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV. Methods Mol Biol 2201:139\u2013162","journal-title":"Methods Mol Biol"},{"key":"10082_CR27","doi-asserted-by":"crossref","unstructured":"Nash B, Tarn K, Irollo E, Luchetta J, Festa L, Halcrow P, Datta G, Geiger JD, Meucci O (2019) Morphine-Induced Modulation of Endolysosomal Iron Mediates Upregulation of Ferritin Heavy Chain in Cortical Neurons. eNeuro 6","DOI":"10.1523\/ENEURO.0237-19.2019"},{"key":"10082_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.physiol.64.081501.160008","volume":"64","author":"EA Nimchinsky","year":"2002","unstructured":"Nimchinsky EA, Sabatini BL, Svoboda K (2002) Structure and function of dendritic spines. Annu Rev Physiol 64:313\u2013353","journal-title":"Annu Rev Physiol"},{"key":"10082_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-017-0058-1","volume":"14","author":"SM Patton","year":"2017","unstructured":"Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ, Bush WS, Samuels DC, Franklin DR, Kaur H, Iudicello J, Grant I, Kallianpur AR (2017) Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Fluids Barriers CNS 14:11","journal-title":"Fluids Barriers CNS"},{"key":"10082_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1471-4159.2011.07578.x","volume":"120","author":"I Pelizzoni","year":"2012","unstructured":"Pelizzoni I, Zacchetti D, Smith CP, Grohovaz F, Codazzi F (2012) Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J Neurochem 120:269\u2013278","journal-title":"J Neurochem"},{"key":"10082_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1172\/JCI70090","volume":"124","author":"J Pitcher","year":"2014","unstructured":"Pitcher J, Abt A, Myers J, Han R, Snyder M, Graziano A, Festa L, Kutzler M, Garcia F, Gao WJ, Fischer-Smith T, Rappaport J, Meucci O (2014) Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction. J Clin Invest 124:656\u2013669","journal-title":"J Clin Invest"},{"key":"10082_CR32","doi-asserted-by":"crossref","unstructured":"Porras CA, Rouault TA (2022) Iron Homeostasis in the CNS: An Overview of the Pathological Consequences of Iron Metabolism Disruption. Int J Mol Sci 23","DOI":"10.3390\/ijms23094490"},{"key":"10082_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12035-013-8465-z","volume":"48","author":"M Rodriguez-Munoz","year":"2013","unstructured":"Rodriguez-Munoz M, Garzon J (2013) Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. Mol Neurobiol 48:769\u2013782","journal-title":"Mol Neurobiol"},{"key":"10082_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3453","volume":"14","author":"TA Rouault","year":"2013","unstructured":"Rouault TA (2013) Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 14:551\u2013564","journal-title":"Nat Rev Neurosci"},{"key":"10082_CR35","doi-asserted-by":"crossref","unstructured":"Santi C, Scimmi C, Sancineto L (2021) Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation. Molecules 26","DOI":"10.3390\/molecules26144230"},{"key":"10082_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder\u2013pathogenesis and prospects for treatment. Nat Rev Neurol 12:234\u2013248","journal-title":"Nat Rev Neurol"},{"key":"10082_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0379-0738(03)00067-7","volume":"133","author":"P Schmidt","year":"2003","unstructured":"Schmidt P, Schmolke C, Musshoff F, Menzen M, Prohaska C, Madea B (2003) Area-specific increased density of mu-opioid receptor immunoreactive neurons in the cerebral cortex of drug-related fatalities. Forensic Sci Int 133:204\u2013211","journal-title":"Forensic Sci Int"},{"key":"10082_CR38","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1523\/JNEUROSCI.5865-08.2009","volume":"29","author":"R Sengupta","year":"2009","unstructured":"Sengupta R, Burbassi S, Shimizu S, Cappello S, Vallee RB, Rubin JB, Meucci O (2009) Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J Neurosci 29:2534\u20132544","journal-title":"J Neurosci"},{"key":"10082_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/B978-0-12-394316-3.00005-3","volume":"70","author":"A Shawki","year":"2012","unstructured":"Shawki A, Knight PB, Maliken BD, Niespodzany EJ, Mackenzie B (2012) H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics. Curr Top Membr 70:169\u2013214","journal-title":"Curr Top Membr"},{"key":"10082_CR40","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1089\/ars.2012.4931","volume":"20","author":"N Singh","year":"2014","unstructured":"Singh N, Haldar S, Tripathi AK, Horback K, Wong J, Sharma D, Beserra A, Suda S, Anbalagan C, Dev S, Mukhopadhyay CK, Singh A (2014) Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal 20:1324\u20131363","journal-title":"Antioxid Redox Signal"},{"key":"10082_CR41","first-page":"19","volume":"8","author":"T Skjorringe","year":"2015","unstructured":"Skjorringe T, Burkhart A, Johnsen KB, Moos T (2015) Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front Mol Neurosci 8:19","journal-title":"Front Mol Neurosci"},{"key":"10082_CR42","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1091\/mbc.e02-03-0165","volume":"13","author":"M Tabuchi","year":"2002","unstructured":"Tabuchi M, Tanaka N, Nishida-Kitayama J, Ohno H, Kishi F (2002) Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol Biol Cell 13:4371\u20134387","journal-title":"Mol Biol Cell"},{"key":"10082_CR43","doi-asserted-by":"publisher","first-page":"22220","DOI":"10.1074\/jbc.M001478200","volume":"275","author":"M Tabuchi","year":"2000","unstructured":"Tabuchi M, Yoshimori T, Yamaguchi K, Yoshida T, Kishi F (2000) Human NRAMP2\/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem 275:22220\u201322228","journal-title":"J Biol Chem"},{"key":"10082_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0306-4522(00)00124-X","volume":"98","author":"K Taki","year":"2000","unstructured":"Taki K, Kaneko T, Mizuno N (2000) A group of cortical interneurons expressing mu-opioid receptor-like immunoreactivity: a double immunofluorescence study in the rat cerebral cortex. Neuroscience 98:221\u2013231","journal-title":"Neuroscience"},{"key":"10082_CR45","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","volume":"99","author":"FM Torti","year":"2002","unstructured":"Torti FM, Torti SV (2002) Regulation of ferritin genes and protein. Blood 99:3505\u20133516","journal-title":"Blood"},{"key":"10082_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/37610","volume":"390","author":"CW Vaughan","year":"1997","unstructured":"Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390:611\u2013614","journal-title":"Nature"},{"key":"10082_CR47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.chembiol.2006.08.005","volume":"13","author":"HA Wetli","year":"2006","unstructured":"Wetli HA, Buckett PD, Wessling-Resnick M (2006) Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Chem Biol 13:965\u2013972","journal-title":"Chem Biol"},{"key":"10082_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13041-016-0220-8","volume":"9","author":"RS White","year":"2016","unstructured":"White RS, Bhattacharya AK, Chen Y, Byrd M, McMullen MF, Siegel SJ, Carlson GC, Kim SF (2016) Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1. Mol Brain 9:38","journal-title":"Mol Brain"},{"key":"10082_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","volume":"133","author":"I Yanatori","year":"2019","unstructured":"Yanatori I, Kishi F (2019) DMT1 and iron transport. Free Radic Biol Med 133:55\u201363","journal-title":"Free Radic Biol Med"},{"key":"10082_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.451610","volume":"205","author":"W Zieglgansberger","year":"1979","unstructured":"Zieglgansberger W, French ED, Siggins GR, Bloom FE (1979) Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205:415\u2013417","journal-title":"Science"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-023-10082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-023-10082-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-023-10082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:18:12Z","timestamp":1697426292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-023-10082-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10082"],"URL":"https:\/\/doi.org\/10.1007\/s11481-023-10082-x","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animals were kept in Association for Assessment and Accreditation of Laboratory Animal Care-accredited university facilities in accordance with the National Institutes of Health guidelines and institutional approval by the Institutional Animal Care and Use Committee (protocol numbers LA-21-613 \u2013 renewed 4\/1\/22, LA-21-614 \u2013 renewed 4\/1\/22), PHS Animal Welfare Assurance D16-00138.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval for Research Involving Animals"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}